News

Jeff Slezak, MS, is a collaborative biostatistician research scientist for the Division of Epidemiologic Research in the Department of Research & Evaluation. He is focused on the application of statistics to improve knowledge and patient care. He has more than 25 years of experience as a statistician, including work on numerous prostate cancer research studies. Can ...

While physical activity is vital for the health and well-being of children and adults, people aren’t doing enough of it, said Deborah Rohm Young, PhD, MBA, of the Kaiser Permanente Southern California Department of Research & Evaluation. One way Dr. Young sought to change that was to lead an effort to create a policy statement for ...

Fewer than half of the people observed outdoors in Philadelphia were wearing masks correctly, according to research spearheaded by Deborah Cohen, MD, MPH, of Kaiser Permanente Southern California Department of Research & Evaluation and Philadelphia-based Studio Ludo—a nonprofit focused on building better play through research, design, and advocacy. The study found that 51% of people on ...

Jaejin An, PhD, is a research scientist in the Division of Epidemiologic Research and a pharmacoepidemiologist whose work focuses on understanding medication utilization, medication adherence, and disease management patterns.

People who were overweight were less likely to have tried to lose weight if their primary care provider had not talked with them about weight loss, a Kaiser Permanente study found. “By delivering factual information on weight status, primary care providers may motivate their patients to consider weight management strategies,” said Deborah Rohm Young, PhD, the ...

In a study published in the New England Journal of Medicine, Kaiser Permanente Southern California research scientists report that while atypical femur fracture risk is rare, it does increase with longer use of bisphosphonate to treat osteoporosis, especially after 5 years. Asian women had approximately 5 times the risk of these fractures with prolonged bisphosphonate ...

In a study published in Annals of Internal Medicine, Kaiser Permanente research shows that obesity was associated with a substantial increased risk of death from COVID-19. However, it also found that the risk of death from COVID-19 associated with obesity is not uniform among those who are obese, but instead disproportionately affects men and people ...

Today, Kaiser Permanente began participating in a phase 3 clinical trial to test an investigational vaccine against SARS-CoV-2, the virus causing the current COVID-19 global pandemic. Kaiser Permanente plans to enroll approximately 1,400 participants at 4 sites in California and Oregon. The goal for this trial is to enroll up to 30,000 participants at more ...